How does zinc chelation affect liver sphingolipid metabolism in an Alzheimer's-like model?
Journal of Trace Elements in Medicine and Biology · 2025
DOI: 10.1016/j.jtemb.2025.127589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Trace Elements in Medicine and Biology, 2025. Verfasst von Ebru Afşar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Dentistry, Kapadokya University, Esbelli, Nevsehir 50400, Turkey. Electronic address: ebru.afsar@kapadokya.edu.tr. Hauptthemen laut MEDLINE: Alzheimer Disease, Sphingolipids, Liver, Zinc. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Istanbul Kültür University.
Themen: Demenz
Abstract (Originalsprache)
BACKGROUND: The present study aimed to evaluate the impact of Cyclo-Z, a combination of Cyclo (His-Pro) plus zinc, on hepatic sphingolipid (SL) metabolism and antioxidant properties in a rat model of Alzheimer's disease (AD). METHODS: Alzheimer's disease rat model created via intracerebroventricular (i.c.v.) amyloid beta-42 oligomer (AβO) injection into the lateral ventricles. Cyclo-Z administration was performed with daily gavage for 3 weeks after the AβO injection. Ceramide, ceramide kinase (CERK), sphingosine 1 phosphate (S1P), glutathione (GSH), total oxidant capacity (TOS), 4-hydroxynonenal (HNE) and caspase-3 levels were measured with Elisa kit in liver tissue. RESULTS: S1P, CERK and GSH levels increased and ceramide, TOS, 4 HNE, and caspase-3 levels decreased in the liver tissues of AD group. Cyclo-Z treatment decreased S1P, CERK, ceramide and caspase-3 levels but increased TOS and 4-HNE levels in the liver tissues of AD group. CONCLUSION: These results showed that SL metabolism was modulated to generate an anti-apoptotic defense system in liver tissue of AD rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Dentistry, Kapadokya University, Esbelli, Nevsehir 50400, Turkey. Electronic address: ebru.afsar@kapadokya.edu.tr.
- Department of Biophysics, Faculty of Medicine, Akdeniz University, Arapsuyu, Antalya 07070, Turkey. Electronic address: dkantar@akdeniz.edu.tr.
Förderung
- Istanbul Kültür University
Zitieren
APA
Afşar, E., & Kantar, D. (2025). How does zinc chelation affect liver sphingolipid metabolism in an Alzheimer's-like model?. Journal of Trace Elements in Medicine and Biology. https://doi.org/10.1016/j.jtemb.2025.127589
Vancouver
Afşar E, Kantar D. How does zinc chelation affect liver sphingolipid metabolism in an Alzheimer's-like model?. Journal of Trace Elements in Medicine and Biology. 2025. doi:10.1016/j.jtemb.2025.127589
BibTeX
@article{Afar2025,
author = {Afşar, Ebru and Kantar, Deniz},
title = {How does zinc chelation affect liver sphingolipid metabolism in an Alzheimer's-like model?},
journal = {Journal of Trace Elements in Medicine and Biology},
year = {2025},
doi = {10.1016/j.jtemb.2025.127589}
}
EUVIMED